Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bjarne Bach Pedersen

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Ugeskrift for Laeger|July 11, 2006
[Centralization versus decentralization, hematology]Bjarne Bach Pedersen
European Journal of Haematology|May 12, 2010
Reasons for treating secondary AML as de novo AMLLene Sofie Granfeldt Ostgård, Eigil Kjeldsen, Mette Skov Holm, et al.
Leukemia & Lymphoma|December 3, 2005
Rituximab in chronic cold agglutinin disease: a prospective study of 20 patientsClaudia Schöllkopf, Lars Kjeldsen, Ole Weiss Bjerrum, et al.
Journal of the National Cancer Institute|February 3, 2005
Ultraviolet radiation exposure and risk of malignant lymphomasKarin Ekström Smedby, Henrik Hjalgrim, Mads Melbye, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Ugeskrift for Laeger|July 11, 2006
[Centralization versus decentralization, hematology]Bjarne Bach Pedersen
European Journal of Haematology|May 12, 2010
Reasons for treating secondary AML as de novo AMLLene Sofie Granfeldt Ostgård, Eigil Kjeldsen, Mette Skov Holm, et al.
Leukemia & Lymphoma|December 3, 2005
Rituximab in chronic cold agglutinin disease: a prospective study of 20 patientsClaudia Schöllkopf, Lars Kjeldsen, Ole Weiss Bjerrum, et al.
Journal of the National Cancer Institute|February 3, 2005
Ultraviolet radiation exposure and risk of malignant lymphomasKarin Ekström Smedby, Henrik Hjalgrim, Mads Melbye, et al.
Pageof 1